Goldman Sachs Reports 223,444.91 Shares (0.7%) in Astronics (ATRO)
Astronics Corporation is the subject of a Schedule 13G/A disclosing that The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC report beneficial ownership of 223,444.91 shares of common stock, equal to 0.7% of the class.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Astronics Corporation is the subject of a Schedule 13G/A disclosing that The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC report beneficial ownership of 223,444.91 shares of common stock, equal to 0.7% of the class. The cover-page details show 0 shares with sole voting or dispositive power and 223,429.91 shares with shared voting power and 223,444.91 with shared dispositive power.
The filing includes a certification that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. An exhibit identifies Goldman Sachs & Co. LLC as a subsidiary of The Goldman Sachs Group and classifies the filers with broker-dealer and investment-adviser roles.
Positive
- Clear disclosure of beneficial ownership: reporting of 223,444.91 shares (0.7%) provides transparency to the market
- Certification of ordinary-course holding: filers state the securities were acquired and are held in the ordinary course of business and not to influence control
Negative
- None.
Insights
TL;DR: Routine passive disclosure—small, non-controlling stake by Goldman Sachs of 223,444.91 shares (0.7%).
The Schedule 13G/A records a modest beneficial position by Goldman Sachs entities, with all reported holdings below the 5% threshold that typically signals a potentially controlling stake. Voting and dispositive powers are reported as shared, not sole, and the filing contains an explicit certification that the securities are held in the ordinary course of business and not to influence control. For investors, this is a transparency update rather than a material change in ownership or governance.
TL;DR: Joint filing and exhibits clarify ownership structure and confirm no stated intent to influence corporate control.
The joint filing and Exhibit (99.2) document the parent-subsidiary relationship between The Goldman Sachs Group and Goldman Sachs & Co. LLC and classify the subsidiary as a broker-dealer and registered investment adviser. The reporting of shared voting/dispositive power and the certification that holdings are not for control purposes indicate limited governance impact on Astronics. This is standard disclosure aligning with regulatory expectations for institutional holders.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Is this stake held to influence control of Astronics (ATRO)?
Which Goldman entities filed the Schedule 13G/A for ATRO?
Does the filing identify relationships between the filers?
AI-generated analysis. How Rhea-AI works. Not financial advice.